The vasorelaxant effect of evocarpine in isolated aortic strips: mode of action

Eur J Pharmacol. 1988 Oct 11;155(1-2):139-43. doi: 10.1016/0014-2999(88)90411-6.

Abstract

The effect of evocarpine (EVO), a quinolone alkaloid isolated from Evodiae fructus, on Ca2+-blocking activity has been examined. In the isolated rat thoracic aorta evocarpine significantly inhibited the contraction induced by 60 mM K+ with an IC50 of 9.8 microM, and that induced by external Ca2+ in the depolarized muscle in concentrations of 10-100 microM. The relaxant effect of evocarpine and verapamil was antagonized by Bay K8644. The increase of 45Ca2+-influx induced by 60 mM K+ was significantly inhibited by 100 microM evocarpine. In the isolated rabbit thoracic aorta 100 microM evocarpine had no effect on the norepinephrine-induced contraction in normal medium or on the phasic contraction in Ca2+-free medium or on the transient relaxation induced by activation of the Na+ pump. The content of cyclic AMP or cyclic GMP was unchanged. These results suggest that evocarpine inhibits Ca2+ influx through voltage-dependent calcium channels.

MeSH terms

  • Alkaloids / pharmacology*
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / metabolism
  • Biological Transport, Active / drug effects
  • Calcium Radioisotopes
  • Carotid Arteries / drug effects
  • Cyclic AMP / metabolism
  • Cyclic GMP / metabolism
  • Guinea Pigs
  • In Vitro Techniques
  • Isometric Contraction / drug effects
  • Male
  • Muscle Relaxation / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Norepinephrine / pharmacology
  • Potassium / pharmacology
  • Quinolones / pharmacology*
  • Rabbits
  • Rats
  • Rats, Inbred Strains
  • Sodium / metabolism

Substances

  • Alkaloids
  • Calcium Radioisotopes
  • Quinolones
  • evocarpine
  • Sodium
  • Cyclic AMP
  • Cyclic GMP
  • Potassium
  • Norepinephrine